Governmental Non-Pharmaceutical Interventions during the COVID-19 Pandemic and the COPD Exacerbation and Respiratory Infection Rate in Patients with Alpha-1 Antitrypsin Deficiency

Governmental Non-Pharmaceutical Interventions during the COVID-19 Pandemic and the COPD Exacerbation and Respiratory Infection Rate in Patients with Alpha-1 Antitrypsin Deficiency

During the COVID-19 pandemic the number of hospital admissions due to chronic obstructive pulmonary disease (COPD) exacerbations was significantly reduced. The reason for this decline is not fully understood. Governmental non-pharmaceutical interventions (NPI’s), an increase in community treated exa...

Full description

Bibliographic Details
Main Authors: Naomi Nanke Kappe, Noga Alagem, Naveh Tov, Jan Stolk
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:COPD
Subjects:
copd exacerbations
covid-19
respiratory infections
alpha-1 antitrypsin deficiency
public health control measures
Online Access:http://dx.doi.org/10.1080/15412555.2023.2249108

Similar Items

Similar Items